Progenics Pharmaceuticals, Inc. - Investor Relations

Investor Relations

The investor pages that follow are your resource for financial information about Progenics Pharmaceuticals, Inc.. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.

Corporate Presentation

Recent Releases

Dec 20, 2011
Salix and Progenics Announce Positive Highly Statistically Significant Results of Oral Methylnaltrexone for Phase 3 Trial in Chronic, Non-Cancer Pain Subjects with Opioid-Induced Constipation

Nov 9, 2011
Progenics Pharmaceuticals Announces Third Quarter 2011 Financial Results

Nov 8, 2011
Progenics Pharmaceuticals to Participate in Investor Conferences

Events

Feb 2, 2012
ASCO 2012 Genitourinary Cancers Symposium (ASCO GU)

Nov 15, 2011
Lazard Capital Markets Healthcare Conference